City of Hope develops adaptive plug-and-play CAR T technology to attack tumors News-Medical.Net 13:29
Phase 1/2 Trial to Assess CRISPR Therapeutics’ CAR T Therapy in NMOSD and Related Diseases Rare Disease Advisor 23:28 Mon, 21 Sep
FDA Clears Phase 1b/2 Trial of CD20/BCMA CAR T-Cell Therapy in Progressive Multiple Sclerosis Rare Disease Advisor 23:45 Fri, 18 Sep
Rest is Science podcast special on lasting CAR T-cell therapy benefits PodcastingToday 11:38 Fri, 18 Sep
Study shows reprogramming thyroid tumors may improve CAR-T cell therapy Newswise (Press Release) 22:45 Thu, 17 Sep
Armouring GPC3 car T cells for hepatocellular carcinoma: how much is enough and what comes next? Nature.com 13:25 Thu, 17 Sep
Fate Therapeutics To Present Off-The-Shelf car T Portfolio At Acr Convergence 2026 RTT News 14:31 Wed, 16 Sep
Iaso Bio's CD20-Targeted In Vivo car-T Therapy IASO208 Receives FDA Ind Clearance PR Newswire (Press Release) 10:52 Wed, 16 Sep
Senlang/Tempest Option Marks China’s First Global Deal For In Vivo CAR-T Scrip Pharma Intelligence 09:00 Wed, 16 Sep
Single CAR T Injection Eases Multiple Sclerosis Symptoms in Small Trial Singularity Hub 20:53 Tue, 15 Sep
Consensus Recommendations Published for CAR-T Therapy in Adult ALL Hematology Advisor 14:32 Tue, 15 Sep
Allo-HCT After CAR-T Therapy Improves Outcomes for Patients With R/R B-ALL Hematology Advisor 14:32 Tue, 15 Sep
Vyriad Begins Phase 1 Clinical Trial for Lead In Vivo car T Cell Therapy VV169 Following FDA Acceptance of Ind Application Business Wire (Press Release) 14:04 Mon, 14 Sep
Seattle biotech BrainChild Bio raises $116M to advance CAR T therapy for childhood brain cancer GeekWire 17:41 Thu, 10 Sep
Bracco Imaging launches BubbleGen CD3+ T Cell Selection Kit as bead-free alternative for CAR-T manufacturing Manufacturing Chemist 13:07 Wed, 09 Sep
GPC3-specific dnTGFβRII-armoured car T cells for hepatocellular carcinoma Nature.com 11:54 Wed, 09 Sep
Brainchild secures $116M for its car T for childhood brain cancer BioWorld 22:07 Tue, 08 Sep Article paywall
Hcw Biologics Taps Akron Biotech To Market HCW11-006 For car-T Cell Production RTT News 15:35 Tue, 08 Sep
BrainChild Launches With $116m To Test CAR-T In Pediatric Brain Cancer Scrip Pharma Intelligence 12:29 Tue, 08 Sep
STAT Plus: We’re reading about a Bristol CAR-T trial pause, Pfizer offloading a shelved candidate, and more STAT 14:49 Fri, 04 Sep
Curocell’s CAR-T therapy Rimqarto clears key reimbursement hurdle Korea Biomedical Review 05:52 Fri, 04 Sep
Engineering CAR T Cells With mRNA-LNPs: Applying Oncology Learnings To Allergic Diseases Drugs Discovery Online 05:06 Fri, 04 Sep
Developers Pause Clinical Trials of 2 CAR T-Cell Therapies in MG, MS, and Other Conditions Rare Disease Advisor 17:56 Thu, 03 Sep
Typewriter Therapeutics emerges with focus on in vivo car T BioWorld 16:49 Thu, 03 Sep Article paywall
Autoimmune CAR-T faces tough questions after Novartis, Bristol Myers study halts BioPharma Dive 18:27 Wed, 02 Sep
Advances in CAR-T cancer therapy & carbon materials’ hidden defects Chemistry World Magazine 17:58 Wed, 02 Sep
Typewriter Therapeutics Emerges from Stealth with $56 Million Series A Financing to pursue in vivo car T medicines PR Newswire (Press Release) 14:02 Wed, 02 Sep
Novartis, Bristol Myers pause autoimmune CAR-T trials due to safety concerns BioPharma Dive 03:06 Tue, 01 Sep
T-maximum B7-H3-Targeted Allogeneic car-T Therapy MT027 Receives FDA Fast Track Designation, Accelerating Global Development for Intracranial Solid Tumors PR Newswire (Press Release) 13:03 Mon, 31 Aug